Trial · NCT06090110
Vagal Nerve Stimulation in Irritable Bowel Syndrome
This randomized control trial aims to evaluate the effect of transcutaneous auricular vagal nerve stimulation in patients with irritable bowel syndrome. The int
- Status
- Recruiting
- Sponsor
- Maastricht University Medical Center
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 166 participants (planned)
- Start
- Dec 1, 2023
- Primary completion
- Nov 1, 2025
- Conditions
- Irritable Bowel Syndrome
Summary
This randomized control trial aims to evaluate the effect of transcutaneous auricular vagal nerve stimulation in patients with irritable bowel syndrome. The intervention will be 8 weeks of treatment with a vagal nerve stimulator. The main objectives are: * To evaluate the clinical response, defined as a decrease of at least 50 points on the IBS-SSS questionnaire, of the treatment.
Interventions
- Vagal Nerve Stimulation Device
- Sham stimulation Device
Locations
1 country: Netherlands.
| Facility | City | Country |
|---|---|---|
| Maastricht University | Maastricht, Limburg | Netherlands |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.